Enterovirus IgG Control Serum BC133G

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Enterovirus IgG Control Serum
Applications: ELISA
IgG control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC133G Categories: control serum, Virion/Serion kits Tags: ELISA control serum, Enterovirus, IgG

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Enterovirus reactive IgG
species reactivity	Enterovirus
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Enterovirus IgG Control Serum BC133G

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Enterovirus Antigen (BA133VS01) Enterovirus IgA Control Serum (BC133A) Enterovirus IgG Control Serum (BC133G) Enterovirus IgM Control Serum (BC133M) Enterovirus IgA ELISA Kit (ESR133A) Enterovirus IgG ELISA Kit (ESR133G) Enterovirus IgM ELISA Kit (ESR133M)

target relevance

human antibody anti-Enterovirus

Enterovirus

Description
Group of viruses that cause respiratory, neurological, gastrointestinal, and systemic infections

Structure
Enteroviruses are non-enveloped, positive-sense, single-stranded RNA viruses belonging to the genus Enterovirus within the family Picornaviridae. The genus comprises numerous human pathogens, including polioviruses, coxsackieviruses, echoviruses, rhinoviruses, and enterovirus A71, among others. Enteroviruses possess an icosahedral capsid that protects the viral genome and contributes to remarkable environmental stability and resistance to many disinfectants. Transmission occurs primarily through the fecal-oral route, respiratory secretions, and direct contact with contaminated surfaces. Following infection, the viruses typically replicate in the gastrointestinal tract and upper respiratory tract before disseminating through the bloodstream to other tissues and organs. Enteroviruses are among the most common viral pathogens worldwide and are responsible for a broad spectrum of clinical diseases ranging from mild febrile illness to severe neurological disease.

Diagnosis
The diagnosis of enterovirus infection is performed through molecular, virological, and serological methods. Reverse transcription polymerase chain reaction (RT-PCR) is the preferred diagnostic technique due to its high sensitivity and specificity and can detect enteroviral RNA in respiratory specimens, stool samples, blood, cerebrospinal fluid, and tissue samples. Viral culture may be used in specialized laboratories but has largely been replaced by molecular testing. Serological assays may assist in epidemiological investigations and retrospective diagnosis but are less commonly used in routine clinical practice. Laboratory confirmation is particularly important in cases involving meningitis, encephalitis, myocarditis, neonatal sepsis-like illness, or outbreak investigations.

Symptoms
Enterovirus infections produce a wide range of clinical manifestations depending on the infecting strain and affected organ systems. Many infections are asymptomatic or result in mild febrile illness characterized by fever, fatigue, headache, sore throat, and gastrointestinal symptoms. Common clinical syndromes include hand, foot and mouth disease, herpangina, viral meningitis, encephalitis, myocarditis, pericarditis, conjunctivitis, and respiratory tract infections. Certain enteroviruses, such as poliovirus and enterovirus D68, can cause severe neurological disease including acute flaccid paralysis. Neonates, immunocompromised individuals, and patients with cardiac or neurological involvement are at increased risk of severe disease. While most infections are self-limiting, some may result in long-term neurological or cardiac complications.

Data

FAQ & Publications

Frequently Asked Questions

What is the intended application for the Enterovirus IgG Control Serum BC133G?

The Enterovirus IgG Control Serum BC133G is designed for use as a control in ELISA assays, specifically for indirect and quantitative detection of enterovirus-reactive IgG antibodies.

How should the Enterovirus IgG Control Serum BC133G be stored to maintain its stability?

The control serum should be stored refrigerated at 2-8°C to ensure stability and preserve its reactivity.

Is the Enterovirus IgG Control Serum BC133G ready to use or does it require dilution before application?

This control serum is provided ready-to-use and is pre-diluted specifically for compatibility with SERION ELISA classic and SERION ELISA antigen assays.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC133G protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Enterovirus IgG Control Serum BC133G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Enterovirus IgM Control Serum BC133M

Cytomegalovirus IgG Control Serum BC109G

Brucella IgG Control Serum BC116G

Borrelia burgdorferi IgG Control Serum BC121G

Echovirus IgG Control Serum BC135G

Bordetella pertussis IgG Control Serum BC120G

Echinococcus IgG Control Serum BC107G

Aspergillus fumigatus IgG Control Serum BC132G

Diphtheria IgG Control Serum BC130G

Adenovirus IgG Control Serum BC128G

Coxsackie IgG Virus Control Serum BC134G

Chlamydia trachomatis IgG Control Serum BC1372G

Chlamydia pneumoniae IgG Control Serum BC1371G

Candida albicans IgG Control Serum BC117G

Campylobacter jejuni IgG Control Serum BC139G